At Rapid Micro Biosystems, it is our commitment to support life-saving therapies, one patient at a time. With cell and gene therapy development on the rise, quality control (QC) microbiology labs must evolve to handle more complex processes, unique scale-up needs, reduced “vein-to-vein” timelines, and demanding requirements for lot release to ensure safe delivery to patients whose time-sensitive lives are on the line. Fortunately, careful planning and advanced technologies can open the door to productive and safe scale-up manufacturing. Discover how our automation technology can enable the safe, rapid release of your critical therapies.
Adapting QC Microbiology Labs for the Demands of Cell & Gene Therapies